NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Incannex Healthcare Limited (AU: IHL)

 
IHL Technical Analysis
5
As on 11th Jul 2023 IHL STOCK Price closed @ 0.11 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.35 & Strong Sell for SHORT-TERM with Stoploss of 0.55 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IHLSTOCK Price

Open 0.11 Change Price %
High 0.11 1 Day 0.00 0.00
Low 0.10 1 Week 0.01 10.00
Close 0.11 1 Month -0.01 -8.33
Volume 4147261 1 Year -0.45 -80.36
52 Week High 0.73 | 52 Week Low 0.10
 
AU Australia Most Active Stocks
MOB 0.02 100.00%
SI6 0.01 %
GMN 0.01 0.00%
LPD 0.01 0.00%
LDX 0.06 -14.29%
S32 3.69 3.65%
WWI 0.02 100.00%
HWK 0.09 %
SYA 0.19 5.56%
G88 0.05 -16.67%
 
AU Australia Top Gainers Stocks
CLB 1.10 2100.00%
CLB 1.10 2100.00%
CLB 1.10 2100.00%
APV 0.02 100.00%
CDT 0.02 100.00%
CDT 0.02 100.00%
EMP 0.02 100.00%
EMP 0.02 100.00%
EMP 0.02 100.00%
MOB 0.02 100.00%
 
AU Australia Top Losers Stocks
VMS 0.01 -50.00%
VMS 0.01 -50.00%
VAR 0.01 -50.00%
VAR 0.01 -50.00%
VAR 0.01 -50.00%
FFG 0.01 -50.00%
HT8 0.01 -50.00%
AQD 0.01 -50.00%
MCL 0.05 -37.50%
MCL 0.05 -37.50%
 
 
IHL
Daily Charts
IHL
Intraday Charts
Whats New @
Bazaartrend
IHL
Free Analysis
 
IHL Important Levels Intraday
RESISTANCE0.13
RESISTANCE0.12
RESISTANCE0.12
RESISTANCE0.12
SUPPORT0.10
SUPPORT0.10
SUPPORT0.10
SUPPORT0.09
 
IHL Forecast May 2024
4th UP Forecast0.77
3rd UP Forecast0.56
2nd UP Forecast0.43
1st UP Forecast0.3
1st DOWN Forecast-0.08
2nd DOWN Forecast-0.21
3rd DOWN Forecast-0.34
4th DOWN Forecast-0.55
 
IHL Weekly Forecast
4th UP Forecast0.28
3rd UP Forecast0.23
2nd UP Forecast0.19
1st UP Forecast0.16
1st DOWN Forecast0.06
2nd DOWN Forecast0.03
3rd DOWN Forecast-0.01
4th DOWN Forecast-0.06
 
IHL Forecast2024
4th UP Forecast1.38
3rd UP Forecast0.97
2nd UP Forecast0.72
1st UP Forecast0.47
1st DOWN Forecast-0.25
2nd DOWN Forecast-0.5
3rd DOWN Forecast-0.75
4th DOWN Forecast-1.16
 
 
IHL Other Details
Segment EQ
Market Capital 453198784.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
IHL Address
IHL
 
IHL Latest News
 
Your Comments and Response on Incannex Healthcare Limited
 
IHL Business Profile
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated 2001 and is based in Sydney, Australia. Address: 207/11 Solent Circuit, Sydney, NSW, Australia, 2153
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service